Synthesis of dynamic riboflavin derivatives and the study of their ability to urease photoinactivation

Authors

  • A Martynov Mechnikov Institute of Microbiology and Immunology, Ukraine https://orcid.org/0000-0003-1428-0085
  • T Bomko Mechnikov Institute of Microbiology and Immunology,
  • T Nosalskaya Mechnikov Institute of Microbiology and Immunology, Ukraine
  • B Farber Noigel LLC,, United States
  • I Kleyn R&D department of Noigel LLC, United States

Keywords:

riboflavin, photodynamic, vaccine, urease, dynamic combinatorial derivatives

Abstract

Introduction. In one patents demonstrated the riboflavin ability to inactivate vaccine strains of viruses and bacteria, as well as cancer cells during the production of vaccines . DNA and RNA within living organisms have specific aptamers or flavin places where Riboflavin and its derivatives are able to selectively join . Upon further blue light irradiation 440-450 nm or ultraviolet light at 280-350 nm such complexes between nucleic acids and riboflavin observed selective nucleolysis nucleic acids in the field of riboflavin attachment .Research aim was to synthesize a series of riboflavin derivatives, including dynamic derivative having greater photodynamic activity (higher sensitivity to light) in the visible region spectrum at lower concentrations. Materials and methods. For gradient HPLC analysis were used: acetonitrile and lithium perchlorate,  perchloric acid in a kit for chromatograph BD2003. For fixing the UV / spectrum of the synthesized compounds was used spectrophotometer Gene-quant - 1300. To analyze riboflavin succinyl-dynamic systems was used HPLC- system Milichrome A-02. To study the ability of riboflavin derivatives for urease’s photo-inactivation reagents were used: test-system Urease-U and spectrophotometer Gene-quant – 1300 for fixing end of reaction.  In addition, we used a set of chromatography conditions for analysis of riboflavin derivatives: gradient separation of acetonitrile (from 0% to 100%) / 0.05 M lithium perchlorate buffer + 0.01 M perchloric acid at 40 0 C, and fraction detection in UV region. As a comparison, we used substance riboflavin (I). Results and discussion. The main difference of (I) from dynamic riboflavin (IV) is much higher water solubility (up to 2%) for (IV). To compare the efficiency photoinactivation by riboflavin (I) and dynamic riboflavin (IV) was studied photoinactivation efficiency of urease as a model of microbial toxin and its transformation into a toxoid. The photoinactivators effectivity criterion is the ability to inactivate urease by disrupt performance of the active center of the enzyme. In our case - to slow down or completely block the urease ability to catalyze the hydrolysis of urea. Full succinylated derivative (V) acts in minimum effective concentration 0,8 ± 0.1 µg/mL. Dynamic derivative (IV) with an immediate showed activity at a concentration  0.2 ± 0.05 µg/ml and after 24 hours also not changed. The starting riboflavin (I) was very active, regardless to storage time and they active concentration in solution was 1.2 ± 0.2 µg/mL. The effective concentration statistically differed between compounds (I), (IV) and (V) at p≤ 0,05.  Conclusion. The first compound obtained is combinatorial - maleylated / succinylated riboflavin (IV). The synthesized compound (IV) and (V) retain photodynamic activity. The minimum effective concentration of the compound (IV) with an immediate application amounted to 0.2 ± 0.05 µg/mL, whereas for the (V) this value was 0.8 ± 0.1 µg/mL. Active dynamic structure (IV) and even exceed the original riboflavin activity at immediate use after dissolution, it is still unstable and gradually hydrolyzed. The most stable activity possessed source riboflavin (I), its active concentration is not dependent on the storage time of the aqueous solution and was 1.2 ± 0.2 µg/mL.

Author Biographies

A Martynov, Mechnikov Institute of Microbiology and Immunology

Head of Laboratory and Clinical department of Molecular Immiunopharmacology

T Bomko, Mechnikov Institute of Microbiology and Immunology

Senior Scientist

T Nosalskaya, Mechnikov Institute of Microbiology and Immunology

Senior Scientist

B Farber, Noigel LLC,

President

I Kleyn, R&D department of Noigel LLC

Head of clinical division

References

Stanojkovic Z, Antic A, Stojanovic M. Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates. Vojnosanit Pregl. 2011.68(6).P.489-494. doi:10.2298/VSP1106489S

Cardoso DR, Libardi SH, Skibsted LH. Riboflavin as a photosensitizer. Effects on human health and food quality. Food Funct. 2012.3(5). P.487. doi:10.1039/c2fo10246c

Eubanks LM, Dickerson TJ, Janda KD. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A. FEBS Lett. 2005.579(24). P.5361-5364. doi:10.1016/j.febslet.2005.08.072

Goodrich RP. Preparation of vaccnes usinga photosenstizer and light. US Patent US7186543B1 2007.

Burgstaller P, Famulok M. Flavin-dependent photocleavage of RNA at GU base pairs. J Am Chem Soc. 1997.119(5). P. 1137-1138. doi:10.1021/ja962918p

Joshi PC, Keane TC. Investigation of riboflavin sensitized degradation of purine and pyrimidine derivatives of DNA and RNA under UVA and UVB. Biochem Biophys Res Commun. 2010.400(4). P.729-733. doi:10.1016/j.bbrc.2010.08.138

Takimoto K, Tano K, Hashimoto M, Hori M, Akasaka S, Utsumi H. Delayed transfection of DNA after riboflavin mediated photosensitization increases G:C to C:G transversions of supF gene in Escherichia coli mutY strain. Mutat Res - Genet Toxicol Environ Mutagen. 1999.445(1). P. 93-98. doi:10.1016/S1383-5718(99)00138-2

Sharma A, Krause A, Worgall S. Recent developments for Pseudomonas vaccines. Hum Vaccin. 2011.7(10).P. 999-1011. doi:10.4161/hv.7.10.16369

Larson RA, Stackhouse PL, Crowley TO. Riboflavin Tetraacetate: A Potentially Useful Photosensitizing Agent for the Treatment of Contaminated Waters. Environ Sci Technol. 1992.26(9). P. 1792-1798. doi:10.1021/es00033a013

Goodrich ymond P, And MC, Goodrich RP, Cardoso M, Marschner S. Vitamin B2 and Innovations in Improving Blood Safety. Intech open. 2018. 2. P.64. doi:10.5772/32009

Upadhyay LSB. Urease inhibitors: A review. Indian J Biotechnol. 2012.11(4). P.381-388.

Farber BS, Martynov AV, Kleyn IR. Creation of New Medical Drugs Based on Triz and Computer Mathematical Modeling. AMI. 2018.(4). P. 15-34. doi:10.5281/zenodo.2547580

Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, Mills KHG. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol Bordetella. 2005.175(2). P.730-738. doi:175/2/730 [pii]

Downloads

How to Cite

Martynov, A., Bomko, T., Nosalskaya, T., Farber, B., & Kleyn, I. (2019). Synthesis of dynamic riboflavin derivatives and the study of their ability to urease photoinactivation. Annals of Mechnikov’s Institute, (3), 44–49. Retrieved from https://journals.uran.ua/ami/article/view/185602

Issue

Section

Research Articles